US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist

1.830
-0.030-1.61%

Close Jul 11 16:00 ET

1.920
+0.090+4.92%

Post 19:56 ET

73.31MMarket Cap-1989P/E (TTM)

Cognition Therapeutics Stock Forum

Trytosaveabit

Jul 2 06:35

Watching for this!

$Cognition Therapeutics(CGTX.US)$

Jaguar8

May 21 06:32

$Cognition Therapeutics(CGTX.US)$
NEWS
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
Cognition Therapeutics (NASDAQ: CGTX) released the eighth episode of its Conversations video podcast titled “Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease.” This episode explores how beta amyloid (Aβ) oligomers lead to synaptic dysfunction and cognitive decline. The podcast discusses recent researc...

Stock_Drift

May 13 21:07

5/14/24 🦍’s watchlist.🚨🚨🚨

$Advent Technologies(ADN.US)$ $Tian Ruixiang(TIRX.US)$ $Cyclacel Pharmaceuticals(CYCC.US)$ $WaveDancer(WAVD.US)$ $Cognition Therapeutics(CGTX.US)$

Trytosaveabit

May 13 13:20

Update

$Cognition Therapeutics(CGTX.US)$ Cognition Therapeutics To Be Issued US Patent Number 11,981,636 Titled "COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES (INCLUDING ALZHEIMER'S DISEASE AND COGNITIVE DECLINE)"

Jaguar8

May 13 13:15

$Cognition Therapeutics(CGTX.US)$
NEWS
Cognition Therapeutics To Be Issued US Patent Number 11,981,636 Titled "COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES (INCLUDING ALZHEIMER'S DISEASE AND COGNITIVE DECLINE)"

Trytosaveabit

Apr 29 06:35

Make a note!

$Cognition Therapeutics(CGTX.US)$ Cognition Therapeutics Inc: Top-Line Results Are Expected in Second Half of 2024 After Last Participants Have Completed Six Months of Treatment

Jaguar8

Apr 29 06:31

$Cognition Therapeutics(CGTX.US)$
NEWS
Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies

Trytosaveabit

Jan 4 12:17

So let’s see if this patent News get some attention! NEWS!

$Cognition Therapeutics(CGTX.US)$ Cognition Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 17/537,110 Titled "Compositions For Treating Neurodegenerative Diseases (Including Alzheimer's Disease And Cognitive Decline)"